Patient Safety Organizations: Voluntary Relinquishment From the Empire State Patient Safety Assurance Network PSO, 21232-21233 [2017-09091]
Download as PDF
21232
Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–09089 Filed 5–4–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment From the
Healogics Patient Safety Institute
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of Delisting.
AGENCY:
The Patient Safety Rule
authorizes AHRQ, on behalf of the
Secretary of HHS, to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety Act and Patient Safety Rule,
when a PSO chooses to voluntarily
relinquish its status as a PSO for any
reason, or when a PSO’s listing expires.
AHRQ has accepted a notification of
voluntary relinquishment from the
Healogics Patient Safety Institute of its
status as a PSO, and has delisted the
PSO accordingly. The Healogics Patient
Safety Institute submitted this request
for voluntary relinquishment after
receiving a Notice of Preliminary
Finding of Deficiency.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
ET (2400) on March 21, 2017.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT:
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, Room 06N94B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
SRADOVICH on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:43 May 04, 2017
Jkt 241001
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety and Quality
Improvement Act of 2005, (Patient
Safety Act) and the related Patient
Safety and Quality Improvement Final
Rule, (Patient Safety Rule), published in
the Federal Register on November 21,
2008, establish a framework by which
hospitals, doctors, and other health care
providers may voluntarily report
information to Patient Safety
Organizations (PSOs), on a privileged
and confidential basis, for the
aggregation and analysis of patient
safety events.
The Patient Safety and Quality
Improvement Act of 2005, 42 U.S.C.
299b–21 to b–26, (Patient Safety Act)
and the related Patient Safety and
Quality Improvement Final Rule, 42
CFR part 3 (Patient Safety Rule),
published in the Federal Register on
November 21, 2008, 73 FR 70732–
70814, establish a framework by which
hospitals, doctors, and other health care
providers may voluntarily report
information to Patient Safety
Organizations (PSOs), on a privileged
and confidential basis, for the
aggregation and analysis of patient
safety events.
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
federally approved PSOs.
AHRQ has accepted a notification
from the Healogics Patient Safety
Institute, a component entity of
Healogics, Inc., PSO number P0169, to
voluntarily relinquish its status as a
PSO. Accordingly, the Healogics Patient
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Safety Institute was delisted effective at
12:00 Midnight EDT (2400) on March
21, 2017. AHRQ notes that the Healogics
Patient Safety Institute submitted this
request for voluntary relinquishment
following receipt of the Notice of
Preliminary Finding of Deficiency sent
to the PSO on February 22, 2017.
Healogics Patient Safety Institute has
patient safety work product (PSWP) in
its possession. The PSO will meet the
requirements of Section 3.108(c)(2)(i) of
the Patient Safety Rule regarding
notification to providers that have
reported to the PSO. In addition,
according to Sections 3.108(c)(2)(ii) and
3.108(b)(3) of the Patient Safety Rule
regarding disposition of PSWP, the PSO
has 90 days from the effective date of
delisting and revocation to complete the
disposition of PSWP that is currently in
the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.ahrq.gov.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–09088 Filed 5–4–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment From the
Empire State Patient Safety Assurance
Network PSO
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of delisting.
AGENCY:
The Patient Safety and
Quality Improvement Act of 2005,
(Patient Safety Act) and the related
Patient Safety and Quality Improvement
Final Rule, published in the Federal
Register on November 21, 2008, 73 FR
70732–70814, establish a framework by
which hospitals, doctors, and other
health care providers may voluntarily
report information to Patient Safety
Organizations (PSOs), on a privileged
and confidential basis, for the
aggregation and analysis of patient
safety events. The Patient Safety Rule
authorizes AHRQ, on behalf of the
Secretary of HHS, to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety Act and Patient Safety Rule,
SUMMARY:
E:\FR\FM\05MYN1.SGM
05MYN1
Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices
SRADOVICH on DSK3GMQ082PROD with NOTICES
when a PSO chooses to voluntarily
relinquish its status as a PSO for any
reason, or when a PSO’s listing expires.
AHRQ has accepted a notification of
voluntary relinquishment from the
Empire State Patient Safety Assurance
Network PSO of its status as a PSO, and
has delisted the PSO accordingly.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
ET (2400) on March 30, 2017.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT:
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, Room 06N94B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
product (PSWP) in its possession. The
PSO will meet the requirements of
Section 3.108(c)(2)(i) of the Patient
Safety Rule regarding notification to
providers that have reported to the PSO.
In addition, according to Sections
3.108(c)(2)(ii) and 3.108(b)(3) of the
Patient Safety Rule regarding
disposition of PSWP, the PSO has 90
days from the effective date of delisting
and revocation to complete the
disposition of PSWP that is currently in
the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.ahrq.gov.
Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
federally approved PSOs.
AHRQ has accepted a notification
from the Empire State Patient Safety
Assurance Network, PSO, a component
entity of the University of Buffalo, PSO
number P0048, to voluntarily relinquish
its status as a PSO. Accordingly, the
Empire State Patient Safety Assurance
Network, PSO was delisted effective at
12:00 Midnight ET (2400) on March 30,
2017.
Empire State Patient Safety Assurance
Network, PSO has patient safety work
Agency Information Collection
Activities: Proposed Collection;
Comment Request
VerDate Sep<11>2014
17:43 May 04, 2017
Jkt 241001
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–09091 Filed 5–4–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project: ‘‘The
AHRQ Safety Program for Improving
Antibiotic Use.’’
DATES: Comments on this notice must be
received by July 5, 2017.
ADDRESSES: Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
email at doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Proposed Project
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3521,
AHRQ invites the public to comment on
this proposed information collection.
Antibiotics can have serious adverse
effects including Clostridium difficile
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
21233
infections (CDI), organ dysfunction,
allergic reactions, and the development
of antibiotic resistance on both a patient
level and population level. This project
will assist acute care, long-term care and
ambulatory care settings across the
United States in adopting and
implementing antibiotic stewardship
programs, which are coordinated efforts
to improve the use of antibiotics by
promoting the selection of the optimal
antibiotic regimen, dose, route of
administration, and duration of therapy.
More specifically, this project has the
following goals:
• Identify best practices in the delivery
of antibiotic stewardship in the acute
care, long-term care and ambulatory
care settings
• Adapt the Comprehensive Unit-Based
Safety Program (CUSP) model to
enhance antibiotic stewardship efforts
in the health care settings
• Assess the adoption of CUSP for
antibiotic stewardship and evaluate
the effectiveness of the intervention in
the participating health care systems
• Develop a bundle of technical and
adaptive interventions and associated
tools and educational materials
designed to support enhanced
antibiotic stewardship efforts
• Provide technical assistance and
training to health care organizations
nationwide, using a phased approach,
to implement effective antibiotic
stewardship programs and
interventions
• Improve communication and
teamwork between health care
workers surrounding antibiotic
decision-making
• Improve communication between
health care workers and patients/
families surrounding antibiotic
decision-making
This study is being conducted by
AHRQ through its contractor Johns
Hopkins University, with subcontracted
partner NORC. The AHRQ Safety
Program for Improving Antibiotic Use is
being undertaken pursuant to AHRQ’s
mission to enhance the quality,
appropriateness, and effectiveness of
health services, and access to such
services, through the establishment of a
broad base of scientific research and
through the promotion of improvements
in clinical and health systems practices,
including the prevention of diseases and
other health conditions. 42 U.S.C. 299.
Method of Collection
To achieve the goals of this project the
following data collections will be
implemented:
(1) Structural Assessments: A brief
(five to seven questions), online
E:\FR\FM\05MYN1.SGM
05MYN1
Agencies
[Federal Register Volume 82, Number 86 (Friday, May 5, 2017)]
[Notices]
[Pages 21232-21233]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09091]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment From the
Empire State Patient Safety Assurance Network PSO
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Act of 2005,
(Patient Safety Act) and the related Patient Safety and Quality
Improvement Final Rule, published in the Federal Register on November
21, 2008, 73 FR 70732-70814, establish a framework by which hospitals,
doctors, and other health care providers may voluntarily report
information to Patient Safety Organizations (PSOs), on a privileged and
confidential basis, for the aggregation and analysis of patient safety
events. The Patient Safety Rule authorizes AHRQ, on behalf of the
Secretary of HHS, to list as a PSO an entity that attests that it meets
the statutory and regulatory requirements for listing. A PSO can be
``delisted'' by the Secretary if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule,
[[Page 21233]]
when a PSO chooses to voluntarily relinquish its status as a PSO for
any reason, or when a PSO's listing expires. AHRQ has accepted a
notification of voluntary relinquishment from the Empire State Patient
Safety Assurance Network PSO of its status as a PSO, and has delisted
the PSO accordingly.
DATES: The directories for both listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. The delisting was effective at 12:00
Midnight ET (2400) on March 30, 2017.
ADDRESSES: Both directories can be accessed electronically at the
following HHS Web site: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, Room 06N94B,
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local):
(301) 427-1130; Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
attests that it meets the statutory and regulatory requirements for
listing. A PSO can be ``delisted'' if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of federally approved PSOs.
AHRQ has accepted a notification from the Empire State Patient
Safety Assurance Network, PSO, a component entity of the University of
Buffalo, PSO number P0048, to voluntarily relinquish its status as a
PSO. Accordingly, the Empire State Patient Safety Assurance Network,
PSO was delisted effective at 12:00 Midnight ET (2400) on March 30,
2017.
Empire State Patient Safety Assurance Network, PSO has patient
safety work product (PSWP) in its possession. The PSO will meet the
requirements of Section 3.108(c)(2)(i) of the Patient Safety Rule
regarding notification to providers that have reported to the PSO. In
addition, according to Sections 3.108(c)(2)(ii) and 3.108(b)(3) of the
Patient Safety Rule regarding disposition of PSWP, the PSO has 90 days
from the effective date of delisting and revocation to complete the
disposition of PSWP that is currently in the PSO's possession.
More information on PSOs can be obtained through AHRQ's PSO Web
site at https://www.pso.ahrq.gov.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-09091 Filed 5-4-17; 8:45 am]
BILLING CODE 4160-90-P